BridgeMD
New treatment option for OCD
Official title Objective Characterizatoion of Repetitive Behaviors
ClinicalTrials.gov ID: NCT06050369
What this study is testing
- What it's testing
- Introduction: Repetitive behaviors (RB) constitute a broad range of symptoms across different psychiatric/neurologic disorders. The most famous are stereotypies (found in autism), compulsions (found in obsessive-compulsive-disorder, OCD) and tics (found in Gilles de la Tourette syndrome, GTS).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 65
You may be able to join if
- To be more of 15 years old or less than 65 years old
- To suffer from OCD and/or GTS (depressive, anxious and attention deficit hyperactivity disorder (ADHD) comorbidities are accepted)
- To be registered to the french social security (or something equivalent)
- To give written consent to participate to the research
- To have contraception for women participants (or to not have any sexual activity)
You likely can't join if
- Patients with any other psychiatric disorders than those mentioned in the inclusion criteria
- Patients with any other neurological disorder than GTS
- Patients who are not able to take decisions for themselves
- Pregnant women
- Patients not allowed to get MRI due to contraindication
- Patients not speaking french
The study team makes the final eligibility decision.
Where it's taking place
- Créteil, France
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Créteil, France; Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.